Literature DB >> 30007296

Risk of progressive chronic kidney disease in individuals with early-onset type 2 diabetes: a prospective cohort study.

Jian-Jun Liu1, Sylvia Liu1, Resham L Gurung1, Keven Ang1, Wern Ee Tang2, Chee Fang Sum3, Subramaniam Tavintharan3, Su Chi Lim3,4.   

Abstract

BACKGROUND: The progression trajectory of renal filtration function has not been well characterized in patients with early-onset type 2 diabetes mellitus (T2DM) although albuminuria is often reported in this population. We aim to study the risk of progressive chronic kidney disease (CKD) in individuals with early-onset T2DM.
METHODS: In total, 1189 T2DM participants were followed for 3.9 (interquartile range 3.2-4.7) years. Progressive CKD was defined as estimated glomerular filtration rate (eGFR) decline of ≥5 mL/min/1.73 m2 per year. Early-onset T2DM was defined as age at T2DM diagnosis between 18 and 30 years.
RESULTS: Compared with later-onset counterparts (N = 1032), participants with early-onset T2DM (N = 157) were more obese and had poorer glycaemic control at baseline. In the follow-up, 24.2% and 15.6% experienced progressive CKD in early-onset and later-onset participants, respectively (P = 0.007). Logistic regression suggested that participants with early-onset T2DM had 2.63-fold [95% confidence interval (CI) 1.46-4.75] higher risk of progressive CKD after accounting for multiple traditional risk factors. Furthermore, the excess risk of progressive CKD associated with early-onset T2DM mainly occurred in participants with preserved renal function [eGFR ≥60 mL/min/1.73 m2, odds ratio (OR) 2.85, 95% CI 1.50-5.42] and was more pronounced in those with diabetes duration <10 years (OR 3.67, 95% CI 1.51-8.90).
CONCLUSIONS: Individuals with early-onset T2DM have a higher risk of progressive CKD. The excess risk mainly exhibits in early stage of CKD and cannot be solely attributed to traditional risk factors and a longer diabetes duration.
© The Author(s) 2018. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved.

Entities:  

Keywords:  chronic kidney disease; diabetic kidney disease; early-onset; renal progression; type 2 diabetes mellitus

Year:  2020        PMID: 30007296     DOI: 10.1093/ndt/gfy211

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  6 in total

1.  Clinical Features and Vitreous Biomarkers of Early-Onset Type 2 Diabetes Mellitus Complicated with Proliferative Diabetic Retinopathy.

Authors:  DanDan Ke; YiYi Hong; XinNan Jiang; XuFang Sun
Journal:  Diabetes Metab Syndr Obes       Date:  2022-04-26       Impact factor: 3.249

2.  Early-Onset Type 2 Diabetes as a Risk Factor for End-Stage Renal Disease in Patients With Diabetic Kidney Disease.

Authors:  Li Zheng; Xiangjun Chen; Ting Luo; Xi Ran; Jinbo Hu; Qingfeng Cheng; Shumin Yang; Jinshan Wu; Qifu Li; Zhihong Wang
Journal:  Prev Chronic Dis       Date:  2020-07-02       Impact factor: 2.830

Review 3.  Diabetic kidney disease: new clinical and therapeutic issues. Joint position statement of the Italian Diabetes Society and the Italian Society of Nephrology on "The natural history of diabetic kidney disease and treatment of hyperglycemia in patients with type 2 diabetes and impaired renal function".

Authors:  Giuseppe Pugliese; Giuseppe Penno; Andrea Natali; Federica Barutta; Salvatore Di Paolo; Gianpaolo Reboldi; Loreto Gesualdo; Luca De Nicola
Journal:  J Nephrol       Date:  2020-02       Impact factor: 3.902

4.  Genetically determined blood lead is associated with reduced renal function amongst individuals with type 2 diabetes mellitus: insight from Mendelian Randomisation.

Authors:  Mohsen Mazidi; Richard Kirwan; Ian G Davies
Journal:  J Mol Med (Berl)       Date:  2021-10-18       Impact factor: 4.599

5.  Development and validation of a risk prediction model for chronic kidney disease among individuals with type 2 diabetes.

Authors:  Cheng-Chieh Lin; May Jingchee Niu; Chia-Ing Li; Chiu-Shong Liu; Chih-Hsueh Lin; Shing-Yu Yang; Tsai-Chung Li
Journal:  Sci Rep       Date:  2022-03-21       Impact factor: 4.379

6.  Rate of decline in kidney function and known age-of-onset or duration of type 2 diabetes.

Authors:  Oyunchimeg Buyadaa; Agus Salim; Jedidiah I Morton; Dianna J Magliano; Jonathan E Shaw
Journal:  Sci Rep       Date:  2021-07-19       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.